Director's Messages

Fall 2017

It began as an experiment four years ago. UC San Diego Altman Clinical and Translational Research Institute (ACTRI) and UC San Diego Institute of Engineering in Medicine (IEM) launched an initiative to bring physicians and engineers together to develop and implement novel engineering solutions for specific unmet medical needs. Since establishing the Galvanizing Engineering in Medicine (GEM) program, we have awarded 15 physician-engineer teams with diverse and innovative projects. Successful examples include a home system to predict cystic fibrosis flares; injectable biomaterial for treating pelvic floor disorders; 3-D printable, disposable endoscopes; and epidermal electronics technology for minimally invasive monitoring of brain function in newborns. more

Summer 2017

I am delighted to announce four new leaders at UC San Diego Altman Clinical and Translational Research Institute (ACTRI). They offer special expertise and fresh insight in the areas of biomedical informatics, computational biology, clinical trials, and mentoring of the next generation of translational scientists. By continuously adding and refreshing the outstanding talent that works at the ACTRI, we aim to facilitate research, support our less experienced investigators, and provide new tools at UC San Diego for our investigators. more

Spring 2017

I am pleased to announce our participation in two new NIH initiatives that create nationwide networks to support critical facets of clinical trials: The Trial Innovation Network (TIN) and the Accrual to Clinical Trials program (ACT). UC San Diego Altman Clinical and Translational Research Institute (ACTRI) serves as the local link to these exciting new efforts. The goal of the TIN is to provide consultation and services for the design and initiation of new multi-center clinical trials, while ACT provides new tools for assessing study feasibility. more

Winter 2016-2017

Obtaining preliminary data is essential to the success of early-stage clinical studies, and is the cornerstone for receiving federal or foundation support for larger scale studies. Last year, the Altman Clinical and Translational Research Institute (ACTRI) implemented a Vouchers Program to enable researchers to gather preliminary results for grant submissions. more

Summer 2016

I’m very pleased to announce the opening of our expanded Center for Clinical Research (CCR) at our new home, the Altman Clinical and Translational Research Institute (CTRI). This fully staffed clinic includes 18,000 square feet of the first floor and supports a wide range of translational research studies. The CCR opened following a brief gap in operations during the move. The clinic staff did an outstanding job preparing the clinic space for clinical trials and participants. Since opening its doors in June, 276 participants have used the space. more

Spring 2016

I am delighted to announce we will begin moving into our new home, the Altman Clinical and Translational Research Institute (ACTRI) building, this spring. We are preparing for this phased move as the finishing touches are being added to the ACTRI. On March 4, under sunny skies, we dedicated the building during a ribbon cutting celebration. more

Winter 2016

I am pleased to announce expanded programs in our Education unit at the UC San Diego CTRI. Our new NIH grant, awarded in August, enables us to develop additional education and training opportunities for a growing workforce. I’m especially pleased about the growth of our successful KL2 program, the addition of the TL1 postdoctoral program, and our launch of new courses and seminars. more

 

Past Director's Messages

2012 - 2015